Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06712901 · ClinicalTrials.gov registry record · NA
Social Media and Cancer Screening Information
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 2,030
- Enrollment target
NCT06712901: Completed NA study, sponsored by University of Utah.
NCT06712901 is a NA study that has completed, run by University of Utah. The registered enrollment target is 2,030 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06712901, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,030 participants
- Enrollment target
Study Summary
NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.
Primary Outcome
After reading cancer screening (CRCS) recommendations, this outcome will assess how likely they are to follow on the the screening recommendations. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Median Ranked Cancer Screening Messaging
- BEHAVIORAL Overall Preferred Cancer Screening Messaging
- BEHAVIORAL Black American Preferred Cancer Screening Messaging
- BEHAVIORAL White American Preferred Cancer Screening Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,030 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2025-01-21 |
| Phase | NA |
What the finished NCT06712901 record still lists
NCT06712901 is an interventional study that assigns participants to a tested intervention. Its 2,030 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% higher).
The record links to 0 conditions, and to 5 interventions - of which Control is the first listed.
NCT06712901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06712901 about?
NCT06712901 is a clinical study titled "Social Media and Cancer Screening Information". NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messa...
What is the current status of trial NCT06712901?
This trial is currently completed. It is a NA study. The enrollment target is 2,030 participants. The study started on 2025-01-09. Estimated completion is 2025-01-21.
What interventions are being tested in trial NCT06712901?
The interventions under investigation include: Control (BEHAVIORAL), Median Ranked Cancer Screening Messaging (BEHAVIORAL), Overall Preferred Cancer Screening Messaging (BEHAVIORAL), Black American Preferred Cancer Screening Messaging (BEHAVIORAL), White American Preferred Cancer Screening Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06712901?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06712901's enrollment target sits among peer trials
2,030 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI